全文获取类型
收费全文 | 2176篇 |
免费 | 211篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 37篇 |
儿科学 | 107篇 |
妇产科学 | 36篇 |
基础医学 | 225篇 |
口腔科学 | 42篇 |
临床医学 | 288篇 |
内科学 | 631篇 |
皮肤病学 | 33篇 |
神经病学 | 102篇 |
特种医学 | 209篇 |
外科学 | 179篇 |
综合类 | 48篇 |
预防医学 | 194篇 |
眼科学 | 29篇 |
药学 | 133篇 |
1篇 | |
中国医学 | 9篇 |
肿瘤学 | 130篇 |
出版年
2021年 | 18篇 |
2020年 | 18篇 |
2019年 | 18篇 |
2018年 | 49篇 |
2017年 | 30篇 |
2016年 | 46篇 |
2015年 | 44篇 |
2014年 | 60篇 |
2013年 | 75篇 |
2012年 | 65篇 |
2011年 | 81篇 |
2010年 | 80篇 |
2009年 | 87篇 |
2008年 | 108篇 |
2007年 | 117篇 |
2006年 | 71篇 |
2005年 | 88篇 |
2004年 | 61篇 |
2003年 | 68篇 |
2002年 | 44篇 |
2001年 | 55篇 |
2000年 | 46篇 |
1999年 | 59篇 |
1998年 | 86篇 |
1997年 | 92篇 |
1996年 | 69篇 |
1995年 | 66篇 |
1994年 | 41篇 |
1993年 | 52篇 |
1992年 | 39篇 |
1991年 | 36篇 |
1990年 | 38篇 |
1989年 | 51篇 |
1988年 | 42篇 |
1987年 | 46篇 |
1986年 | 22篇 |
1985年 | 35篇 |
1984年 | 27篇 |
1983年 | 29篇 |
1982年 | 21篇 |
1981年 | 13篇 |
1980年 | 13篇 |
1979年 | 17篇 |
1978年 | 21篇 |
1977年 | 21篇 |
1976年 | 21篇 |
1974年 | 17篇 |
1973年 | 12篇 |
1972年 | 19篇 |
1968年 | 17篇 |
排序方式: 共有2433条查询结果,搜索用时 125 毫秒
71.
Plasma adrenomedullin and obstructive sleep apnea 总被引:2,自引:0,他引:2
Wolk R Svatikova A Otto ME Hoffmann MS Duenwald CJ Somers VK 《American journal of hypertension》2004,17(1):74-76
BACKGROUND: Obstructive sleep apnea (OSA) is associated with hypertension. The vasorelaxing peptide adrenomedullin (ADM) may counteract effects of OSA-induced release of vasopressor substances. METHODS: Plasma ADM levels were measured at 9:30 PM, 2:00 AM (after 4 to 5 h of untreated OSA), and 6:00 AM (after 4 h of continuous positive airway pressure treatment) in 15 OSA patients and in 10 controls. RESULTS: Baseline ADM levels were similar in the OSA and control groups (28.7 +/- 6.7 v 27.7 +/- 6.4 pg/mL, respectively), did not change overnight in either group, and were not affected by continuous positive airway pressure. CONCLUSIONS: OSA does not exert any significant acute or chronic effects on plasma ADM levels. 相似文献
72.
73.
Basal and tolbutamide-induced plasma somatostatin in healthy subjects and in patients with diabetes and impaired glucose tolerance 总被引:1,自引:0,他引:1
Peripheral levels of basal and tolbutamide-induced somatostatin have been measured in patients with diabetes or impaired glucose tolerance (IGT) and compared with those in normal individuals. Basal somatostatin was significantly higher in patients with Type 1 diabetes than in age-matched control subjects. This increase was most pronounced at diagnosis, and appeared to be related to metabolic control in insulin-treated patients. No increase was noted in patients with Type 2 diabetes or with IGT. Intravenous bolus injection of tolbutamide enhanced peripheral somatostatin levels in healthy volunteers in a biphasic manner. Patients with IGT also exhibited a biphasic response but the amplitude of the first phase was higher. No secretory response was detected in 27/29 Type 1 diabetic patients at diagnosis; a somatostatin response to tolbutamide became detectable again in Type 1 patients with normalization of their basal somatostatin levels but was then paradoxically related to poor blood glucose control. In Type 2 diabetes, basal somatostatin levels were similar to age-matched control subjects, but decreased upon intravenous tolbutamide administration. 相似文献
74.
Obstructive sleep apnea and hypertension 总被引:4,自引:0,他引:4
There is growing evidence of a causal relationship between obstructive sleep apnea (OSA) and hypertension. Untreated OSA may
have direct and deleterious effects on cardiovascular function and structure through several mechanisms, including sympathetic
activation, oxidative stress, inflammation, and endothelial dysfunction. OSA may contribute to or augment elevated blood pressure
levels in a large proportion of the hypertensive patient population. It is important to consider OSA in the differential diagnosis
of hypertensive patients who are obese. OSA should be especially considered in those hypertensive patients who respond poorly
to combination therapy with antihypertensive medications. 相似文献
75.
ObjectiveThis meta-evaluation aimed to summarize all available evidence regarding different fissure sealants on occlusal caries prevention, arrest, retention rate, adverse effect, and cost-effectiveness; when compared with no intervention, other preventive or minimally-invasive procedures.Materials and MethodsThe systematic reviews and meta-analyses were identified via four electronic databases and manual searching. Two independent reviewers performed study selection, data extraction, quality assessment with AMSTAR-2.ResultsAmong the 366 records yielded, 38 systematic reviews were identified as eligible 24 of them included meta-analyses. Moderate evidence has supported the efficacies of resin-based sealants (RBS) in occlusal caries prevention, arrest and cost-effectiveness compared to no interventions. Low to very low certainty of evidence suggested similar effectiveness of glass-ionomer cements in caries prevention with RBS and more superior performance of resin infiltration in arresting non-cavitated occlusal lesions.ConclusionThis meta-evaluation supports the use of RBS on permanent molars to reduce occlusal caries occurrence, arrest lesion progression and alleviate oral health inequalities between individuals of different socioeconomic status. This meta-evaluation also advocates further research on glass-ionomer cements and resin infiltration with respect to their efficacies in caries prevention and arrest. 相似文献
76.
Dr. Mary Fanning MD PhD FRCP Marc Monte MD Lloyd R. Sutherland MDCM FRCPC FACP MSc Mary Broadhead RN ONC Gerard F. Murphy MD CM MSc Alan G. Harris MD 《Digestive diseases and sciences》1991,36(4):476-480
Seventeen AIDS patients were enrolled in a prospective open-label dose-finding study of octreotide (Sandostatin) therapy for refractory diarrhea. Five were nonevaluable due to progression of AIDS symptomatology, and one was excluded because of lack of confirmation of HIV infection. Five of 11 evaluable patients responded to therapy (45%); two each at 50 g and 100 g, and one at 250 g thrice daily doses. A sixth patient demonstrated a moderate reduction in stool volume at 250 g thrice daily, which, although deemed clinically relevant, did not meet the criteria for response. On discontinuation of therapy, diarrhea recurred in all patients within 1–12 days, and responded to reinitiation of octreotide in those five patients who resumed treatment. Only one of the three patients with concurrent cryptosporidial infection responded to treatment. The drug was well tolerated, with mild symptomatology in three patients. Long-term treatment at a stable dose was effective in three of five treated patients for periods for seven months in one (moderate responder) and one year in two. One patient required dose increases to control symptoms, but after one year of treatment developed severe nausea following injections, which required dose cessation. One patient had partial control of his diarrhea for only three months despite two dose increases. These data suggest that octreotide may be of useful therapeutic value in HIV-associated diarrhea and that further studies are indicated.This study was supported by Sandoz Canada Inc. 相似文献
77.
We have previously reported that lithium chloride (LiCl) stimulates the production of granulocyte-macrophage colony-forming cells (GM-CFC), pluripotent stem cells (CFU-S), and differentiated granulocytes, macrophages and megakaryocytes in murine Dexter marrow cultures and that this effect appears to be mediated indirectly by a radioresistant adherent marrow cell. In this study we have established that exposure of murine Dexter cultures to LiCl (4 mEq/L) causes an increase of colony-forming cell megakaryocytes (CFU-meg) over 1 to 6 weeks of culture in both supernatant (188% to 611%) and stromal phases (123% to 246%). Moreover, we have shown that lithium treatment of either irradiated (1,100 rad) or unirradiated stromal cells increased production of activities stimulating formation of megakaryocyte, granulocyte, macrophage, and mixed lineage colonies and proliferation of the factor-dependent cell line, FDC-P1. This FDC-P1 stimulatory activity was completely blocked by an antibody to purified recombinant granulocyte-macrophage colony stimulating factor (rGM-CSF). The baseline or lithium-induced--stromal-derived bone marrow colony stimulating activity was partially blocked by the antibody to rGM-CSF and by an antibody to purified colony stimulating factor I (CSF-1); the two antibodies combined resulted in greater than 90% inhibition of the lithium-induced marrow stimulatory activity. In addition, radioimmunoassay (RIA) showed that although CSF-1 was detectable in supernatants of these cultures, exposure to lithium did not increase CSF-1 levels. These data indicate that Dexter stromal cells produce CSF- 1 and GM-CSF and that lithium appears to exert its stimulatory effects on in vitro myelopoiesis by inducing production of GM-CSF. 相似文献
78.
Genetic and non‐genetic factors that increase the risk of non‐syndromic cleft lip and/or palate development
下载免费PDF全文
![点击此处可从《Oral diseases》网站下载免费的PDF全文](/ch/ext_images/free.gif)
79.
80.
Kato M Hisatome I Tomikura Y Kotani K Kinugawa T Ogino K Ishida K Igawa O Shigemasa C Somers VK 《The American journal of cardiology》2005,96(11):1576-1578
Hyperuricemia has been associated with an increased risk for cardiovascular disease and increased mortality. However, the biologic mechanisms that link elevated serum uric acid to cardiovascular disease are uncertain. This study tested the hypothesis that elevated serum uric acid is associated with impaired endothelial function in hyperuricemic patients without any overt cardiovascular disease. Seventeen male patients with hyperuricemia (mean age 42+/-4 years) and 9 control subjects (mean age 45+/-5 years) were studied. All subjects were nonsmokers. All patients had never been treated for hyperuricemia, were on no medications, and were free of any other known diseases. Endothelial function was evaluated by flow-mediated dilation measured by ultrasound. Flow-mediated dilation was significantly impaired in patients with hyperuricemia (4.0+/-0.7%) compared with control subjects (6.4+/-0.8%) (p=0.044). Flow-mediated dilation correlated inversely with uric acid levels (r=-0.4, p=0.05). Nitrate-induced dilation was 12.3+/-1.0% in patients with hyperuricemia and 11.8+/-2.3% in control subjects (p=0.82). Impaired endothelial-dependent vasodilation is present in hyperuricemic patients even in the absence of any overt cardiovascular disease. The elevated serum uric acid, per se, may constitute a novel risk factor for endothelial dysfunction. 相似文献